{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:10:00Z","timestamp":1793157000670,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T00:00:00Z","timestamp":1365465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s10096-013-1873-1","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T06:36:14Z","timestamp":1365402974000},"page":"1225-1230","source":"Crossref","is-referenced-by-count":48,"title":["Listeriosis in patients receiving biologic therapies"],"prefix":"10.1007","volume":"32","author":[{"given":"M.","family":"Bodro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,9]]},"reference":[{"issue":"7","key":"1873_CR1","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/art.11151","volume":"48","author":"MG Netea","year":"2003","unstructured":"Netea MG, Radstake T, Joosten LA, van der Meer JW, Barrera P, Kullberg BJ (2003) Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and toll-like receptor 4 expression. Arthritis Rheum 48(7):1853\u20131857","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1873_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cyto.2004.12.012","volume":"30","author":"C Popa","year":"2005","unstructured":"Popa C, Netea MG, Barrera P, Radstake TR, van Riel PL, Kullberg BJ, Van der Meer JW (2005) Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy. Cytokine 30(2):72\u201377","journal-title":"Cytokine"},{"issue":"1","key":"1873_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1432-1033.1991.tb16337.x","volume":"202","author":"G Camussi","year":"1991","unstructured":"Camussi G, Albano E, Tetta C, Bussolino F (1991) The molecular action of tumor necrosis factor-alpha. Eur J Biochem 202(1):3\u201314","journal-title":"Eur J Biochem"},{"issue":"3","key":"1873_CR4","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/IAI.69.3.1847-1855.2001","volume":"69","author":"VP Mohan","year":"2001","unstructured":"Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E, Tsai MM, Flynn JL, Chan J (2001) Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69(3):1847\u20131855","journal-title":"Infect Immun"},{"issue":"8","key":"1873_CR5","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.4049\/jimmunol.174.8.4852","volume":"174","author":"BM Saunders","year":"2005","unstructured":"Saunders BM, Tran S, Ruuls S, Sedgwick JD, Briscoe H, Britton WJ (2005) Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol 174(8):4852\u20134859","journal-title":"J Immunol"},{"key":"1873_CR6","volume-title":"Immunobiology: the immune system in health and disease","author":"CA Janeway","year":"1999","unstructured":"Janeway CA, Travers P, Walport M, Capra JD (1999) Immunobiology: the immune system in health and disease. Elsevier Science, London"},{"issue":"9","key":"1873_CR7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38(9):1261\u20131265","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1873_CR8","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","volume":"54","author":"WG Dixon","year":"2006","unstructured":"Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register (2006) Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54(8):2368\u20132376","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1873_CR9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.10758","volume":"48","author":"NR Slifman","year":"2003","unstructured":"Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM (2003) Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 48(2):319\u2013324","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1873_CR10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4321\/S1130-01082010001000014","volume":"102","author":"JM Ramos","year":"2010","unstructured":"Ramos JM, Garc\u00eda-Sepulcre MF, Masi\u00e1 M, Brotons A, Grau MC, Guti\u00e9rrez F (2010) Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy. Rev Esp Enferm Dig 102(10):614\u2013616","journal-title":"Rev Esp Enferm Dig"},{"issue":"4","key":"1873_CR11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","volume":"70","author":"D Salmon-Ceron","year":"2011","unstructured":"Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, Cuillerier E, Fautrel B, Michelet C, Morel J, Pu\u00e9chal X, Wendling D, Lemann M, Ravaud P, Mariette X; RATIO group (2011) Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis 70(4):616\u2013623","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1873_CR12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cgh.2007.02.016","volume":"5","author":"RA Hansen","year":"2007","unstructured":"Hansen RA, Gartlehner G, Powell GE, Sandler RS (2007) Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol 5(6):729\u2013735","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6440","key":"1873_CR13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/364798a0","volume":"364","author":"J Rothe","year":"1993","unstructured":"Rothe J, Lesslauer W, L\u00f6tscher H, Lang Y, Koebel P, K\u00f6ntgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364(6440):798\u2013802","journal-title":"Nature"},{"issue":"10","key":"1873_CR14","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1128\/IAI.56.10.2563-2569.1988","volume":"56","author":"A Nakane","year":"1988","unstructured":"Nakane A, Minagawa T, Kato K (1988) Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun 56(10):2563\u20132569","journal-title":"Infect Immun"},{"key":"1873_CR15","unstructured":"United States Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) reports. Available online at: http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm083765.htm"},{"issue":"5","key":"1873_CR16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jinf.2010.02.009","volume":"60","author":"T Kelesidis","year":"2010","unstructured":"Kelesidis T, Salhotra A, Fleisher J, Uslan DZ (2010) Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections? J Infect 60(5):386\u2013396","journal-title":"J Infect"},{"issue":"5","key":"1873_CR17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1155\/2005\/814698","volume":"16","author":"G Williams","year":"2005","unstructured":"Williams G, Khan AA, Schweiger F (2005) Listeria meningitis complicating infliximab treatment for Crohn\u2019s disease. Can J Infect Dis Med Microbiol 16(5):289\u2013292","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"11","key":"1873_CR18","first-page":"829","volume":"5","author":"N Tweezer-Zaks","year":"2003","unstructured":"Tweezer-Zaks N, Shiloach E, Spivak A, Rapoport M, Novis B, Langevitz P (2003) Listeria monocytogenes sepsis in patients treated with anti-tumor necrosis factor-alpha. Isr Med Assoc J 5(11):829\u2013830","journal-title":"Isr Med Assoc J"},{"issue":"3","key":"1873_CR19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1572-0241.2000.01872.x","volume":"95","author":"J Morelli","year":"2000","unstructured":"Morelli J, Wilson FA (2000) Does administration of infliximab increase susceptibility to listeriosis? Am J Gastroenterol 95(3):841\u2013842","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"1873_CR20","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s10067-007-0660-8","volume":"26","author":"T Kesteman","year":"2007","unstructured":"Kesteman T, Yombi JC, Gigi J, Durez P (2007) Listeria infections associated with infliximab: case reports. Clin Rheumatol 26(12):2173\u20132175","journal-title":"Clin Rheumatol"},{"issue":"4","key":"1873_CR21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00005176-200204000-00018","volume":"34","author":"BM Kamath","year":"2002","unstructured":"Kamath BM, Mamula P, Baldassano RN, Markowitz JE (2002) Listeria meningitis after treatment with infliximab. J Pediatr Gastroenterol Nutr 34(4):410\u2013412","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"1873_CR22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ibd.20286","volume":"14","author":"F Izb\u00e9ki","year":"2008","unstructured":"Izb\u00e9ki F, Nagy F, Szepes Z, Kiss I, Lonovics J, Moln\u00e1r T (2008) Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn\u2019s disease. Inflamm Bowel Dis 14(3):429\u2013431","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1873_CR23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1345\/aph.1D151","volume":"38","author":"VL Bowie","year":"2004","unstructured":"Bowie VL, Snella KA, Gopalachar AS, Bharadwaj P (2004) Listeria meningitis associated with infliximab. Ann Pharmacother 38(1):58\u201361","journal-title":"Ann Pharmacother"},{"issue":"6","key":"1873_CR24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/gut.2003.018515","volume":"53","author":"T Ljung","year":"2004","unstructured":"Ljung T, Karl\u00e9n P, Schmidt D, Hellstr\u00f6m PM, Lapidus A, Janczewska I, Sj\u00f6qvist U, L\u00f6fberg R (2004) Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut 53(6):849\u2013853","journal-title":"Gut"},{"issue":"8","key":"1873_CR25","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/art.10374","volume":"46","author":"T Gl\u00fcck","year":"2002","unstructured":"Gl\u00fcck T, Linde HJ, Sch\u00f6lmerich J, M\u00fcller-Ladner U, Fiehn C, Bohland P (2002) Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases. Arthritis Rheum 46(8):2255\u20132257, author reply 2257","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1873_CR26","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.11019","volume":"48","author":"AG Aparicio","year":"2003","unstructured":"Aparicio AG, Mu\u00f1oz-Fern\u00e1ndez S, Bonilla G, Miralles A, Cerde\u00f1o V, Mart\u00edn-Mola E (2003) Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Gl\u00fcck et al. Arthritis Rheum 48(6):1764\u20131765, author reply 1765\u20131766","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1873_CR27","first-page":"854","volume":"26","author":"JL Pe\u00f1a-Sagredo","year":"2008","unstructured":"Pe\u00f1a-Sagredo JL, Hern\u00e1ndez MV, Fernandez-Llanio N, Gim\u00e9nez-Ubeda E, Mu\u00f1oz-Fern\u00e1ndez S, Ortiz A, Gonzalez-Gay MA, Fari\u00f1as MC; Biobadaser group (2008) Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience. Clin Exp Rheumatol 26(5):854\u2013859","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"1873_CR28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/605637","volume":"49","author":"N Fern\u00e0ndez-Sab\u00e9","year":"2009","unstructured":"Fern\u00e0ndez-Sab\u00e9 N, Cervera C, L\u00f3pez-Medrano F, Llano M, S\u00e1ez E, Len O, Fort\u00fan J, Blanes M, Laporta R, Torre-Cisneros J, Gavald\u00e0 J, Mu\u00f1oz P, Fari\u00f1as MC, Mar\u00eda Aguado J, Moreno A, Carratal\u00e0 J (2009) Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case\u2013control study. Clin Infect Dis 49(8):1153\u20131159","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1873_CR29","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00365529850171765","volume":"33","author":"M Chiba","year":"1998","unstructured":"Chiba M, Fukushima T, Koganei K, Nakamura N, Masamune O (1998) Listeria monocytogenes in the colon in a case of fulminant ulcerative colitis. Scand J Gastroenterol 33(7):778\u2013782","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"1873_CR30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/cid\/cir902","volume":"54","author":"V Goulet","year":"2012","unstructured":"Goulet V, Hebert M, Hedberg C, Laurent E, Vaillant V, De Valk H, Desenclos JC (2012) Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. Clin Infect Dis 54(5):652\u2013660","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"1873_CR31","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1086\/429998","volume":"41","author":"S Ehlers","year":"2005","unstructured":"Ehlers S (2005) Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept? Clin Infect Dis 41(Suppl 3):S199\u2013S203","journal-title":"Clin Infect Dis"},{"issue":"5 Suppl1","key":"1873_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semarthrit.2005.01.009","volume":"34","author":"RS Wallis","year":"2005","unstructured":"Wallis RS, Ehlers S (2005) Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum 34(5 Suppl1):34\u201338","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1873_CR33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","volume":"301","author":"B Scallon","year":"2002","unstructured":"Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D, Wagner C (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301(2):418\u2013426","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"1873_CR34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1503\/cmaj.081377","volume":"179","author":"R Bortolussi","year":"2008","unstructured":"Bortolussi R (2008) Listeriosis: a primer. CMAJ 179(8):795\u2013797","journal-title":"CMAJ"},{"issue":"4","key":"1873_CR35","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/clinids\/14.4.815","volume":"14","author":"K Skogberg","year":"1992","unstructured":"Skogberg K, Syrj\u00e4nen J, Jahkola M, Renkonen OV, Paavonen J, Ahonen J, Kontiainen S, Ruutu P, Valtonen V (1992) Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis 14(4):815\u2013821","journal-title":"Clin Infect Dis"},{"key":"1873_CR36","unstructured":"Centers for Disease Control and Prevention (CDC) disease information. Listeria (Listeriosis). Available online at: http:\/\/www.cdc.gov\/listeria\/ . Accessed 28 Nov 2012"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-1873-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-013-1873-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-1873-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T01:24:05Z","timestamp":1595640245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-013-1873-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1007\/s10096-013-1873-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,9]]}}}